Discover 1,296 paid clinical trials in Gilbert, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,296
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain
for
Chronic Pain, Low Back Pain
Location: Phoenix AZ, San Diego CA, Riverside CA, Austin TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07641504
Phase 2, Recruiting
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain
for
Osteoarthritis, Knee, Chronic Pain
Location: Phoenix AZ, Palm Springs CA, San Diego CA, Riverside CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40+
Code: NCT07641517
Phase 2, Recruiting
New
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Phoenix AZ, Irvine CA, Valley Village CA, Provo UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07775300
Phase 3, Recruiting
New
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
for
Diabetic Macular Edema (DME)
Location: Scottsdale AZ, Encino CA, Aurora CO, Reno NV, Austin TX,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT07867080
Phase 3, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: Phoenix AZ, San Francisco CA, Allen Park MI
Sponsor: Tectonic Operating Company, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07473700
Phase 2, Recruiting
Improving Pain Management and Decreasing LOS After Total Hip Arthroplasty (THA) and Total Knee Arthroplasty (TKA)
for
Pain
Location: Phoenix AZ
Sponsor: More Foundation
Sex: All
Age: 50 - 70+
Code: NCT05307341
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
for
Obesity, Overweight, Chronic Weight Management
Location: Phoenix AZ, San Antonio TX, Austin TX, Evansville IN,
Sponsor: Ascletis Pharma (China) Co., Limited
Sex: All
Age: 18+
Code: NCT07743463
Phase 3, Recruiting
A Comparison of the dermaPACE® (Pulsed Acoustic Cellular Expression) Device in Conjunction With Standard of Care Versus Standard of Care Alone in the Treatment of Diabetic Foot Ulcers
for
Diabetic Foot Ulcers
Location: Phoenix AZ, Tucson AZ, San Bernardino CA, Long Beach CA,
Sponsor: SANUWAVE, Inc.
Sex: All
Age: 22+
Code: NCT01824407
Phase 3, Recruiting
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Phoenix AZ, Tucson AZ, Lone Tree CO, Reno NV, Eugene OR,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase 2, Recruiting
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
for
Endometrial Cancer
Location: Phoenix AZ, Los Angeles CA, Oklahoma City OK,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: Female
Age: 18 - 70
Code: NCT06481592
Phase 2, Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Phoenix AZ, San Diego CA, Los Angeles CA,
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT05911568
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
for
Type B Aortic Dissection
Location: Phoenix AZ, Long Beach CA, Los Angeles CA,
Sponsor: Duke University
Sex: All
Age: 21+
Code: NCT06087029
Recruiting
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
for
Ulcerative Colitis (UC)
Location: Scottsdale AZ, Montreal, Lubbock TX, Palo Alto CA,
Sponsor: Xencor, Inc.
Sex: All
Age: 18 - 70+
Code: NCT06619990
Phase 1, Phase 2, Recruiting
A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO